NexPhase Capital has sold OmniSYS to XIFIN, a portfolio company of Avista Capital Partners
OmniSYS is a healthcare technology company with more than 25 years of experience working with pharmacies, payers, providers and pharmaceutical manufacturers. The company delivers unique market insight and pharmacy workflow expertise to deliver valuable solutions that help pharmacies thrive in the changing pharmacy landscape. These solutions help pharmacies engage patients, grow clinical services and improve financial performance. OmniSYS currently serves over 30,000 pharmacies, connects to hundreds of payers and touches millions of patient lives.
XIFIN is a healthcare information technology company that leverages diagnostic information to improve the quality and economics of healthcare. The company’s cloud-based technology facilitates connectivity and workflow automation for accessing and sharing clinical and financial diagnostic data, linking healthcare stakeholders in the delivery and reimbursement of care. This transaction further expands on XIFIN’s role as a top provider of solutions and services that optimize the billing and claims process, provide healthcare leaders with greater business visibility and support patient engagement. Together, XIFIN and OmniSYS will support retail pharmacies as they transition to a clinical services business model; drive closer relationships between pharmacies and diagnostic providers; and bring together complementary clinical and financial information via integrated, cloud-based technology.
Michael Siano, Managing Director in Lincoln’s Healthcare Group, commented, “As the role of U.S. retail pharmacies expands to include clinical services, there is an immediate need for innovative technology solutions that provide greater connectivity across all constituents, including pharmacies, patients, labs, pharmaceutical manufacturers and payors. XIFIN and OmniSYS provide complementary technology solutions that are purpose built to support this evolution and address the challenges facing U.S. retail pharmacies. We’re excited to have worked with NexPhase and OmniSYS and we look forward to seeing this new partnership drive continued success.”
Meet our Senior Team
View More Transactions in Healthcare
Lincoln International advised Proclinic Group, a portfolio company of Miura Partners, on the acquisition of Meditrans
Lincoln International advised Frazier Lifesciences Acquisition Corporation on merger with NewAmsterdam Pharma Holding
Lincoln International advised Pfingsten Partners on the sale of Full Spectrum Group to CBRE Group
Lincoln International advised Rarebreed, a portfolio company of Trilantic Capital Partners and Halle Capital Management, on receiving significant investment from Revelstoke Capital Partners
Lincoln International advised Corus a portfolio company of Careventures and Quadrum Capital on the refinancing and acquisition of Nordentic
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.